Cargando…

Reduction of tumour cell entry into vessels by BCG-activated macrophages.

Detalles Bibliográficos
Autores principales:	Liotta, L. A., Gattozzi, C., Kleinerman, J., Saidel, G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1977
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025396/ https://www.ncbi.nlm.nih.gov/pubmed/588424

Ejemplares similares

Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG.
por: Castés, M., et al.
Publicado: (1981)

Distant metastasis facilitated by BCG: spread of tumour cells injected in the BCG-primed site.
por: Ishibashi, T., et al.
Publicado: (1980)

NMAAP1 Expressed in BCG-Activated Macrophage Promotes M1 Macrophage Polarization
por: Liu, Qihui, et al.
Publicado: (2015)

Immunotherapy of primary methylcholanthrene-induced mouse tumours by intratumoral BCG.
por: Creau-Goldberg, N., et al.
Publicado: (1980)

Proceedings: Role of immunocompetence in localized BCG suppression of tumour growth.
por: Pimm, M. V., et al.
Publicado: (1975)

Methanol extraction residue of BCG in the treatment of transplanted rat tumours.
por: Hopper, D. G., et al.
Publicado: (1975)

Low Dose BCG Infection as a Model for Macrophage Activation Maintaining Cell Viability
por: Chávez-Galán, Leslie, et al.
Publicado: (2016)

Proceedings: Tumour therapy in dogs using B.C.G.
por: Owen, L. N., et al.
Publicado: (1974)

Exercise Inhibits Doxorubicin-Induced Damage to Cardiac Vessels and Activation of Hippo/YAP-Mediated Apoptosis
por: Tao, Rong-Hua, et al.
Publicado: (2021)

Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages
Publicado: (1975)

BCG Immunotherapy of Pulmonary Growths from Intravenously Transferred Rat Tumour Cells
por: Baldwin, R. W., et al.
Publicado: (1973)

BCG treatment of human tumour xenografts in athymic nude mice.
por: Pimm, M. V., et al.
Publicado: (1978)

Tumor Vessel Development and Expansion in Ewing's Sarcoma: A Review of the Vasculogenesis Process and Clinical Trials with Vascular-Targeting Agents
por: Stewart, Keri S., et al.
Publicado: (2011)

Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels
por: Pflicke, Holger, et al.
Publicado: (2009)

Influence of orally administered B.C.G. on growth of transplanted rat tumours.
por: Baldwin, R. W., et al.
Publicado: (1975)

Distribution of Photofrin between tumour cells and tumour associated macrophages.
por: Korbelik, M., et al.
Publicado: (1991)

Phosphate starvation enhances phagocytosis of Mycobacterium bovis/BCG by macrophages
por: Espinosa-Cueto, Patricia, et al.
Publicado: (2020)

Retinoblastoma tumour cells in central retinal vessels
por: Mohan, Sashwanthi, et al.
Publicado: (2022)

Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.
por: Pryor, K., et al.
Publicado: (1995)

Homology modeling and docking studies of ENPP4: a BCG activated tumoricidal macrophage protein
por: Yan, Dongmei, et al.
Publicado: (2016)

Differential Effects of Mycobacterium bovis BCG on Macrophages and Dendritic Cells from Murine Spleen
por: Xu, Zhengzhong, et al.
Publicado: (2015)

Neuronal Repressor REST Controls Ewing Sarcoma Growth and Metastasis by Affecting Vascular Pericyte Coverage and Vessel Perfusion
por: Zhou, Zhichao, et al.
Publicado: (2020)

Using macrophage activation to augment immunotherapy of established tumours
por: Fridlender, Z G, et al.
Publicado: (2013)

Goldilocks and the BCG: Bacillus Calmette-Guérin Dose Reduction in the Age of Shortage
por: Nikas, Christine V., et al.
Publicado: (2020)

Proceedings: B.C.G. treatment of pleural and peritoneal tumour growth in rats.
por: Pimm, M. V.
Publicado: (1974)

Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.
por: Wainberg, M. A., et al.
Publicado: (1976)

Analysis of Ebola Virus Entry Into Macrophages
por: Dahlmann, Franziska, et al.
Publicado: (2015)

Proceedings: BCG immunotherapy: its interest in association with radiotherapy in the treatment of Lewis tumour in mice.
por: Dubois, J. B., et al.
Publicado: (1975)

Dopamine Receptor Activation Increases HIV Entry into Primary Human Macrophages
por: Gaskill, Peter J., et al.
Publicado: (2014)

Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against Mycobacterium tuberculosis
por: Bickett, Thomas E., et al.
Publicado: (2020)

BCG: Disseminated BCG infection: case report
Publicado: (2022)

Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast
por: Hasebe, T, et al.
Publicado: (2005)

Suppression of tumour growth by orally administered osteopontin is accompanied by alterations in tumour blood vessels
por: Rittling, S R, et al.
Publicado: (2014)

Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages
por: dos Santos, Carina C., et al.
Publicado: (2022)

BCG orchitis
por: Cutrone, Joseph, et al.
Publicado: (2019)

Intense tumour-cell destruction by syngeneic mice: role of macrophages, complement activation and tumour-cell factors.
por: Orbach-Arbouys, S., et al.
Publicado: (1977)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
por: Fletcher, Helen A., et al.
Publicado: (2016)

Anti-tumour activity and store operated calcium entry: new roles in immunology
por: Singh, Kavisha, et al.
Publicado: (2013)

The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG
por: Cahill, Christina, et al.
Publicado: (2021)

BCG Aortitis, a Rare Complication of BCG Therapy
por: Haddad, Joseph, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m9lbad62bhfm07d4lnsahpnfsa